Early Drug Discovery and Development of Novel Cancer Therapeutics Targeting DNA Polymerase Eta (POLH)
Polymerase eta (or Pol η or POLH) is a specialized DNA polymerase that is able to bypass certain blocking lesions, such as those generated by ultraviolet radiation (UVR) or cisplatin, and is deployed to replication foci for translesion synthesis as part of the DNA damage response (DDR). Inherited de...
Enregistré dans:
Auteurs principaux: | David M. Wilson, Matthew A. J. Duncton, Caleb Chang, Christie Lee Luo, Taxiarchis M. Georgiadis, Patricia Pellicena, Ashley M. Deacon, Yang Gao, Debanu Das |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/40bb23ee3ada4b41a46d7f5aa6c07ebc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
DockStream: a docking wrapper to enhance de novo molecular design
par: Jeff Guo, et autres
Publié: (2021) - Drug discoveries & therapeutics
-
Novel Antimicrobials from Uncultured Bacteria Acting against <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
par: Jeffrey Quigley, et autres
Publié: (2020) -
Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs
par: José Manuel Ezquerra-Aznárez, et autres
Publié: (2021) -
Radioligands Targeting Fibroblast Activation Protein (FAP)
par: Thomas Lindner, et autres
Publié: (2021)